Original price was: ₹405.09.₹345.00Current price is: ₹345.00.
Jalra-M 50mg/850mg Tablet
Prescription Required
Marketer: USV Ltd
SALT COMPOSITION: Vildagliptin (50mg) + Metformin (850mg)
15.0 tablets in 1 strip
Description
About Jalra-M 50mg/850mg Tablet
Jalra-M 50mg/850mg Tablet is an oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus in adults.
It combines two well-established agents — Vildagliptin and Metformin — to help achieve better blood sugar control when diet, exercise, and single-drug therapy are not sufficient.
The combination provides dual and complementary mechanisms, targeting both insulin secretion and glucose production.
How It Works
-
Vildagliptin (50mg): A DPP-4 inhibitor that increases incretin hormone levels, leading to enhanced insulin secretion and reduced glucagon release in response to meals.
-
Metformin (850mg): A biguanide that reduces glucose production in the liver, improves insulin sensitivity, and enhances peripheral glucose uptake.
Together, they improve fasting and postprandial (after-meal) glucose control and help prevent diabetes-related complications.
Uses
-
Treatment of Type 2 Diabetes Mellitus
-
Controls both fasting and postprandial blood glucose
-
Reduces the risk of diabetic complications such as neuropathy, nephropathy, and cardiovascular disease
Directions for Use
-
Take once or twice daily, preferably with meals, to minimize gastrointestinal side effects.
-
Swallow whole with water; do not crush or chew.
-
Follow a balanced diet and regular exercise regimen as advised by your doctor.
Side Effects
Common side effects may include:
-
Nausea, vomiting, or stomach discomfort
-
Diarrhea or bloating
-
Headache or dizziness
-
Mild hypoglycemia (especially when taken with other anti-diabetic agents)
Seek medical attention if you notice symptoms of lactic acidosis (muscle pain, rapid breathing, or extreme fatigue) or severe hypoglycemia.
Precautions
-
Avoid alcohol, which may increase the risk of lactic acidosis.
-
Inform your doctor if you have kidney, liver, or heart disorders.
-
Not recommended during pregnancy or breastfeeding unless prescribed.
-
Monitor blood glucose and HbA1c levels regularly.
-
Maintain hydration and avoid skipping meals while on this medication.





